+919993921187
Brimonidine Tartrate Ophthalmic Solution IP

Brimonidine Tartrate Ophthalmic Solution IP

Product Details:

X

Product Description

Brimonidine Tartrate Ophthalmic Solution IP is a medication used to treat intraocular pressure associated with open-angle glaucoma or ocular hypertension. It works by decreasing the amount of fluid in the eye and increasing the drainage of fluid out of the eye, thus reducing the pressure inside the eye.

The medication is administered as eye drops and is applied directly to the eye as directed by a healthcare provider. The dosage of Brimonidine Tartrate Ophthalmic Solution IP will depend on various factors such as the patient's medical history, age, and overall health condition.

It is important to follow the healthcare providers instructions and not to use more or less medication than prescribed. Patients using Brimonidine Tartrate Ophthalmic Solution IP should be aware of the potential side effects such as eye irritation, dry mouth, headache, and dizziness. If any side effects persist or worsen, patients should contact their healthcare provider immediately.

Patients should inform their healthcare provider if they have any medical conditions such as heart disease, depression, or allergies to medications before using Brimonidine Tartrate Ophthalmic Solution IP. Patients should also inform their healthcare provider if they are pregnant, breastfeeding, or taking any other medications or supplements.

Brimonidine Tartrate Ophthalmic Solution IP is generally safe for most patients when used as directed. However, patients should not use this medication if the solution appears to be discolored or if the seal on the bottle is broken. Patients should also avoid touching the tip of the eye dropper to any surface or their eye to prevent contamination.

FAQ

1. What is Brimonidine Tartrate Ophthalmic Solution IP?

Ans - Brimonidine Tartrate Ophthalmic Solution IP is a prescription medication used to reduce pressure within the eye. It is used to treat glaucoma and ocular hypertension.

2. How should Brimonidine Tartrate Ophthalmic Solution IP be used?

Ans - Brimonidine Tartrate Ophthalmic Solution IP should be used as directed by your doctor. Generally, it is applied to the affected eye(s) twice daily. It should not be used for more than 4 weeks without consulting your doctor.

3. What are the potential side effects of Brimonidine Tartrate Ophthalmic Solution IP?

Ans - Common side effects may include dry eye, eye irritation, stinging/burning, blurred vision, and increased tear production. Serious side effects that require immediate medical attention include severe eye redness, vision loss, and eye pain.

4.  Is it safe to use Brimonidine Tartrate Ophthalmic Solution IP while pregnant or breastfeeding?

Ans - Brimonidine Tartrate Ophthalmic Solution IP should not be used during pregnancy or breastfeeding. Consult your doctor for more information.

Enter Buying Requirement Details
Email Id
Mobile number


"We are dealing only bulk order quantity."
Back to top